Results 1 to 10 of about 26,876 (262)

Secondary prevention of suicide. [PDF]

open access: yesPLoS Medicine, 2010
Leo Sher and colleagues discuss recent research on interventions to prevent secondary suicide and discuss the additional research that is needed.
Debora Ganz   +2 more
doaj   +5 more sources

Antiplatelets in secondary stroke prevention [PDF]

open access: yesFrontiers in Neurology, 2011
The aim of this review is to provide evidence-based recommendations on the secondary prevention of atherothrombotic ischemic stroke. Antiplatelets are the major therapy for the secondary stroke prevention.
Olga eShulga, Natan eBornstein
doaj   +4 more sources

Secondary prevention of preeclampsia

open access: yesFrontiers in Cell and Developmental Biology
Preventing preeclampsia (PE) is crucial for the wellbeing of the mother, fetus, and the neonate with three levels: primary, secondary, and tertiary.
Muhammad Ilham Aldika Akbar   +7 more
doaj   +3 more sources

Secondary prevention of meningococcal disease [PDF]

open access: greenBMJ, 1996
Meningococcal disease puts huge pressure on local health officials. General practitioners must of course ensure that the correct diagnosis is made and that initial treatment is given, but referring the patient to hospital is not the end of the job. Meningococcal disease brings anxiety to the affected population, which may itself become a health problem.
Arne-Birger Knapskog   +1 more
openaire   +5 more sources

Secondary prevention of hidradenitis suppurativa

open access: yesDermatology Reports, 2019
Hidradenitis suppurativa (HS) is a multifactorial disease with many facets of uncertain importance for optimal treatment and prevention. In order to explore options for secondary prevention in HS, we randomly and retrospectively selected 40 patients with
Hjalmar Kurzen, Marina Kurzen
doaj   +5 more sources

Bempedoic Acid in Secondary Prevention

open access: yesAmerican Journal of Preventive Cardiology
•Bempedoic acid has been shown to reduce major adverse cardiovascular outcomes in patients unable to take statins due to statin-associated side effects.•Analysis of CLEAR Outcomes trial data reveals possible differences in baseline characteristics between the primary and secondary prevention subgroups.•Further research is needed to optimize use of ...
Idine Mousavi   +7 more
doaj   +3 more sources

Measuring True Change in Individual Patients: Reliable Change Indices of Cardiac Rehabilitation Outcomes, and Implications for Quality Indicators

open access: yesCJC Open, 2021
Background: Mediated by outcomes such as improved exercise capacity, cardiac rehabilitation (CR) reduces morbidity and mortality. For accuracy, an individual CR patient's change must be measured reliably, an issue not typically considered in practice ...
Megan E. O'Connell, PhD   +2 more
doaj   +1 more source

A Nationwide pilot project to develop rehabilitation services for patients with cardiovascular diseases

open access: yesJournal of Rehabilitation Medicine, 2021
Objective: To measure progress towards introducing a 3-phase rehabilitation programme, based on the multidisciplinary approach, for patients with cardiovascular diseases.
Marina Bubnova   +5 more
doaj   +1 more source

The Linkages Between Reimbursement and Prevention: A Mixed-Methods Approach

open access: yesFrontiers in Public Health, 2021
Background: The benefits of prevention are widely recognized; ranging from avoiding disease onset to substantially reducing disease burden, which is especially relevant considering the increasing prevalence of chronic diseases.
Ellen Zwaagstra Salvado   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy